Ph 1 trial results show Covaxin has tolerable safety, enhanced immunity: Lancet study

Bharat Biotech’s intranasal COVID-19 vaccine to enter phase 1 trials next month

Latest Additions

Rishabh Pant becomes most expensive IPL buy at Rs 27 crore, Iyer fetches Rs 26.75 crore deal

Gujarat man held for impersonating govt official, duping people with forged letters

JD(S) first family avoids discussion on Channapatna bypoll debacle

BJP, JD(S) leaders helped win Channapatna bypoll: DK Shivakumar

Virat Kohli doesn’t have anything to prove, his contribution is unparalleled: Kapil Dev

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.